- Home
- VRCA vs RFM Comparison
VRCA vs RFM Comparison
Compare VRCA & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRCA | RFM |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 84.4M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | VRCA | RFM |
|---|---|---|
| Price | $5.60 | $14.39 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 91.9K | 15.0K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,577,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $92.12 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 370.22 | N/A |
| 52 Week Low | $0.39 | $13.59 |
| 52 Week High | $9.82 | $14.90 |
Technical Indicators
Market Signals| Indicator | VRCA | RFM |
|---|---|---|
| Relative Strength Index (RSI) | 51.38 | 58.56 |
| Support Level | $5.18 | $14.20 |
| Resistance Level | $6.48 | $14.53 |
| Average True Range (ATR) | 0.48 | 0.19 |
| MACD | 0.09 | 0.07 |
| Stochastic Oscillator | 73.23 | 82.74 |
Price Performance
Historical ComparisonAbout VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.